Waters Corporation (WAT) Long-Term Debt
The long-term debt for Waters Corporation (WAT) is $947.45 Million with a year-over-year change of -41.75%. Long-term debt includes bonds, term loans, mortgages, and other borrowings with maturities greater than one year. It represents the company's structural leverage.
WAT Long-Term Debt Chart
Current Long-Term Debt
$947.45M
$947.45 Million
Year-over-Year Change
-41.75%
vs. $1.63B prior year
Historical Data
30
Years of data available
Annual Long-Term Debt History
| Year | Long-Term Debt | YoY Change | % Change |
|---|---|---|---|
| 2025 | $947.45M | $-679.04M | -41.75% |
| 2024 | $1.63B | $-679.02M | -29.45% |
| 2023 | $2.31B | +$780.63M | +51.19% |
| 2022 | $1.52B | +$11.01M | +0.73% |
| 2021 | $1.51B | +$307.36M | +25.47% |
| 2020 | $1.21B | $-374.28M | -23.68% |
| 2019 | $1.58B | +$432.63M | +37.68% |
| 2018 | $1.15B | $-749.33M | -39.49% |
| 2017 | $1.90B | +$195.53M | +11.49% |
| 2016 | $1.70B | +$208.94M | +13.99% |
| 2015 | $1.49B | +$255.56M | +20.65% |
| 2014 | $1.24B | +$47.46M | +3.99% |
| 2013 | $1.19B | +$145.00M | +13.88% |
| 2012 | $1.04B | +$345.00M | +49.29% |
| 2011 | $700.00M | +$0 | 0.00% |
| 2010 | $700.00M | +$200.00M | +40.00% |
| 2009 | $500.00M | +$0 | 0.00% |
| 2008 | $500.00M | +$0 | 0.00% |
| 2007 | $500.00M | +$0 | 0.00% |
| 2006 | $500.00M | +$0 | 0.00% |
| 2005 | $500.00M | +$250.00M | +100.00% |
| 2004 | $250.00M | +$125.00M | +100.00% |
| 2003 | $125.00M | +$125.00M | — |
| 2002 | $0 | +$0 | — |
| 2001 | $0 | +$0 | — |
| 2000 | $0 | $-81.10M | -100.00% |
| 1999 | $81.10M | $-137.20M | -62.85% |
| 1998 | $218.30M | $-87.00M | -28.50% |
| 1997 | $305.30M | +$94.80M | +45.04% |
| 1996 | $210.50M | — | — |
About Waters Corporation
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Udit Batra